![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, December 23, 2023 5:42:06 PM
"Have you considered where your valuation may end up six months to two years from now?", asked Jolly. "The market cap is not reflecting the full potential of Enzolytics," said Dr. Chandra, noting the significant market for each of the Company's products. "The next product that we have is ITV-1, which is an HIV therapeutic and has actually cleared Phase III clinical trials and is preparing for introduction into two markets," he explained. "The African market is a significant market because 65% of about 34 to 37 million HIV infected individuals live in Africa."
"We will also be introducing this product into Europe, and are currently awaiting certification under the European Medical Agency," shared Dr. Chandra.
https://www.newsfilecorp.com/release/124101/Enzolytics-Inc.-Discusses-the-Significance-and-Revenue-Potential-of-Its-Therapeutic-Platforms-with-The-Stock-Day-Podcast
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM